title: Low molecular weight heparin-induced thrombocytopenia and thrombosis.
authors.forename: F P
authors.initials: FP
authors.lastname: Peters
authors.forename: P A
authors.initials: PA
authors.lastname: Doevendans
authors.forename: F L
authors.initials: FL
authors.lastname: Erdkamp
authors.forename: F W
authors.initials: FW
authors.lastname: Van Der Ent
authors.forename: F
authors.initials: F
authors.lastname: De Heer
mesh_terms: D000230:Adenocarcinoma / Q000601:surgery*; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000139:chemically induced; D001241:Aspirin / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004617:Embolism / Q000139:chemically induced / Q000601:surgery; D005260:Female; D005263:Femoral Artery; D006493:Heparin; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery*; D009203:Myocardial Infarction / Q000139:chemically induced; D009392:Nephrectomy; D010976:Platelet Count / Q000187:drug effects; D011183:Postoperative Complications / Q000517:prevention & control; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy; D013927:Thrombosis / Q000139:chemically induced* / Q000517:prevention & control
chemical_list: D003911:Dextrans; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D001241:Aspirin